A powerful dopaminergic nootropic combined with a mitochondria-targeting electron carrier for enhanced cognitive function.
9-ME-BC (9-Methyl-β-carboline) is a β-carboline alkaloid that promotes dopamine neuron growth, survival, and function through multiple neuroprotective mechanisms. It was identified in research as a compound capable of stimulating dopaminergic neurogenesis — the growth of new dopamine-producing neurons — making it of significant interest in neurodegenerative disease research. Methylene Blue, the second component, is a phenothiazine dye with well-documented mitochondria-targeting properties that has been used in medicine for over a century. In the brain, Methylene Blue acts as an alternative electron carrier in the mitochondrial respiratory chain, improving ATP production efficiency and reducing the formation of reactive oxygen species. Together, these two compounds address both the dopaminergic and bioenergetic dimensions of cognitive function, making this combination a subject of active nootropic research.
* Benefits based on preclinical/animal research unless otherwise noted.
9-ME-BC inhibits both MAO-A and MAO-B (monoamine oxidase enzymes), reducing dopamine degradation and increasing synaptic dopamine availability. It also upregulates tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis, and promotes BDNF expression to support neuronal survival and plasticity. Methylene Blue acts as a redox cycler in the mitochondrial electron transport chain — accepting electrons from NADH and passing them to cytochrome c, effectively bypassing Complex I/III dysfunction. This improves ATP production, reduces oxidative stress, and has been shown to enhance memory consolidation in animal models. The combined action of dopaminergic enhancement (9-ME-BC) and mitochondrial optimization (Methylene Blue) produces synergistic cognitive benefits that neither compound achieves alone.
Protocol Notes: Take in the morning. Methylene Blue may cause blue-green urine (normal). Avoid with MAOIs or serotonergic drugs.
Store at room temperature, away from light.
When sourcing 9-ME-BC + Methylene Blue (Capsule) for research purposes, the following quality benchmarks should be verified before use.
Store at room temperature, away from light.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Preliminary Evidence — Early-stage research only. Significant uncertainty about efficacy and safety in humans.
Peptides commonly used alongside 9-ME-BC + Methylene Blue (Capsule) for synergistic effects.
Angiotensin IV Analog / Nootropic
An angiotensin IV analog reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
Learn More: Dihexa (Capsule)Comprehensive Nootropic Stack
A comprehensive nootropic stack combining synaptogenesis, anxiolysis, BDNF upregulation, and cellular energy for peak cognitive performance.
Learn More: Dihexa + Selank + Semax + NAD+ (Capsule)